Your browser doesn't support javascript.
loading
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.
Grundmann, Hajo; Glasner, Corinna; Albiger, Barbara; Aanensen, David M; Tomlinson, Chris T; Andrasevic, Arjana Tambic; Cantón, Rafael; Carmeli, Yehuda; Friedrich, Alexander W; Giske, Christian G; Glupczynski, Youri; Gniadkowski, Marek; Livermore, David M; Nordmann, Patrice; Poirel, Laurent; Rossolini, Gian M; Seifert, Harald; Vatopoulos, Alkiviadis; Walsh, Timothy; Woodford, Neil; Monnet, Dominique L.
Afiliação
  • Grundmann H; Department of Infection Prevention and Hospital Hygiene, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Netherlands. Electronic address: hajo.grundmann@uniklinik-freiburg.de.
  • Glasner C; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Netherlands; The Centre for Genomic Pathogen Surveillance, Wellcome Trust Genome Campus, Cambridgeshire, UK.
  • Albiger B; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Aanensen DM; The Centre for Genomic Pathogen Surveillance, Wellcome Trust Genome Campus, Cambridgeshire, UK; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.
  • Tomlinson CT; Department of Surgery and Cancer, South Kensington Campus, Imperial College London, London, UK.
  • Andrasevic AT; Department of Clinical Microbiology, University Hospital for Infectious Diseases, Zagreb, Croatia.
  • Cantón R; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Unidad de Resistencia a Antibióticos y Virulencia Bacteriana asociada al Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
  • Carmeli Y; Division of Epidemiology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel.
  • Friedrich AW; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Netherlands.
  • Giske CG; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
  • Glupczynski Y; Department of Clinical Microbiology, CHU Dinant-Godinne UCL, Namur, Université Catholique de Louvain, Yvoir, Belgium; National Reference Laboratory for Antibiotic Resistance Monitoring in Gram-negative Bacteria, CHU Dinant-Godinne UCL, Namur, Université Catholique de Louvain, Yvoir, Belgium.
  • Gniadkowski M; Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
  • Livermore DM; Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Reference Microbiology Services, Public Health England, London, UK; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Nordmann P; INSERM U914 (Emerging Resistance to Antibiotics), Associated National Reference Center for Antibiotic Resistance, Faculté de Médecine et Université Paris-Sud, K Bicêtre, France; Medical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland.
  • Poirel L; INSERM U914 (Emerging Resistance to Antibiotics), Associated National Reference Center for Antibiotic Resistance, Faculté de Médecine et Université Paris-Sud, K Bicêtre, France; Medical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland.
  • Rossolini GM; Dipartimento di Biotecnologie Mediche, Università di Siena, Siena, Italy; SOD Microbiologia e Virologia, Azienda Ospedaliera-Universitaria Careggi, Fondazione Don Carlo Gnocchi, Firenze, Italy.
  • Seifert H; Institute for Medical Microbiology, Immunology and Hygiene, Cologne University, Cologne, Germany; German Center for Infection Research (DZIF), Braunschweig, Germany.
  • Vatopoulos A; Department of Microbiology, National School of Public Health, Athens, Greece.
  • Walsh T; Section of Medical Microbiology IIB, School of Medical Sciences, Cardiff University, Heath Park Hospital, Cardiff, UK.
  • Woodford N; Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Reference Microbiology Services, Public Health England, London, UK.
  • Monnet DL; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Lancet Infect Dis ; 17(2): 153-163, 2017 02.
Article em En | MEDLINE | ID: mdl-27866944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Beta-Lactamases / Infecções por Klebsiella / Infecções por Escherichia coli / Klebsiella pneumoniae Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Beta-Lactamases / Infecções por Klebsiella / Infecções por Escherichia coli / Klebsiella pneumoniae Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article